Russia approves its third COVID-19 vaccine, CoviVac


  • World
  • Saturday, 20 Feb 2021

FILE PHOTO: Russian Prime Minister Mikhail Mishustin chairs a meeting with senior executives of the Central Office of Russian Government in Moscow, Russia January 19, 2021. Sputnik/Dmitry Astakhov/Pool via REUTERS

MOSCOW (Reuters) - Russia on Saturday approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labelled CoviVac and produced by the Chumakov Centre, have yet to begin.

Russia has already approved two COVID-19 vaccines, including the Sputnik V shot, developed by Moscow's Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Think twice before sharing photos of your kids online, experts say
Brazil's top court evacuates after two nearby explosions, man dead
Sri Lanka votes for new parliament as economic recovery hangs in balance
AMD to lay off 4 pct of its workforce
U.S. stocks stay flat after CPI data
Ukrainian forces repel Russian bid to pierce defences in northeast, General Staff says
Over 100 reported sick in U.S. due to McDonald's E. coli outbreak: CDC
12 killed, 5 wounded in traffic accident in Egypt
Slovakia imports gas from Azerbaijan amid supply security concerns
U.S. stocks close mixed

Others Also Read